RTGN OTC
RetinalGenix Technologies Inc.
1W: +0.0%
1M: -0.2%
3M: -0.2%
YTD: +24.7%
1Y: +12.7%
3Y: -44.2%
$3.99
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
8 relationships8
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-12-30
Earliest Filing
2025-02-20
Latest Filing
acquirer: 3
target: 2
partner: 2
investor: 1
Counterparties (Filed by RTGN)
8 relationshipsCompanies named in RTGN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| RetinalGenix Technologies, Inc. | RTGN | acquirer | Issuer of the warrant and party to the amendment | 2025-02-20 | View |
| Sanovas Ophthalmology, LLC | — | investor | Holder of the warrant and party to the amendment | 2025-02-20 | View |
| RETINALGENIX TECHNOLOGIES, INC. | RTGN | acquirer | Parent company acquiring shares of DNA/GPS Inc. | 2022-07-07 | View |
| DNA/GPS INC. | — | target | Target company whose shares are being exchanged for parent company stock. | 2022-07-07 | View |
| RetinalGenix Technologies, Inc. | RTGN | partner | Termination of Option Exchange Agreement with Diopsys | 2022-02-17 | View |
| Diopsys, Inc. | — | partner | Termination of Option Exchange Agreement with RetinalGenix | 2022-02-17 | View |
| RetinalGenix Technologies Inc. | RTGN | acquirer | Company exchanging securities for pre-funded warrants | 2021-12-30 | View |
| Sanovas Ophthalmology, LLC | — | target | Holder of exchange securities entering into exchange agreement | 2021-12-30 | View |
Recent 8-K Filings (8)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-07-15 | Accountant Change; Exhibits | View | |
| 2026-03-26 | Officer/Director Change | View | |
| 2025-02-20 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-04-08 | Other Events | View | |
| 2023-12-06 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2022-07-07 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi | Agreement Acquisition | View |
| 2022-02-17 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2021-12-30 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR